NCCN updates guidelines for high-grade prostate cancer

Black History Month Conversation with The Cancer Letter

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

Nearly 30 years ago, while completing an assignment for his master’s degree in public health, Brian Rivers discovered he had a family history of prostate cancer.

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Pfizer Inc. announced positive results from the phase III TALAPRO-2 study of Talzenna (talazoparib), an oral poly ADP-ribose polymerase inhibitor, in combination with Xtandi (enzalutamide), an androgen receptor pathway inhibitor, demonstrating a statistically significant and clinically meaningful improvement in overall survival compared to placebo plus Xtandi in patients with metastatic castration-resistant prostate cancer, with or without homologous recombination repair gene mutations.

February 14, 2025

Vol.51 No.06

Clinical Roundup

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

Cortechs.ai and EDAP TMS SA announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco Prostate Center.

February 14, 2025

Vol.51 No.06

Guest Editorial

World Cancer Day 2025: A symbol of personal and collective uncertainty

My entire life I was told to respectfully question anything and everything, because questions equal answers, which provide understanding and thereby comfort—even with the uncomfortable. It’s simply in my DNA.

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center.

February 07, 2025

Vol.51 No.05

Clinical Roundup

Inherited WNT9B mutation linked to increased prostate cancer risk, study finds

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study published in JCO Precision Oncology.

February 07, 2025

Vol.51 No.05

NCCN updates guidelines for high-grade prostate cancer

YOU MAY BE INTERESTED IN

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

World Cancer Day 2025: A symbol of personal and collective uncertainty

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Inherited WNT9B mutation linked to increased prostate cancer risk, study finds

Renew today!

Subscriber content

Never miss an issue!

Login

NCCN updates guidelines for high-grade prostate cancer

YOU MAY BE INTERESTED IN

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America“It gives America, in part, its identity.”

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

World Cancer Day 2025: A symbol of personal and collective uncertainty

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Inherited WNT9B mutation linked to increased prostate cancer risk, study finds

Never miss an issue!

Login

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”